MC Vega, M Rolón, A Montero-Torres… - European journal of …, 2012 - Elsevier
Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic …
Two series of new 5-nitroindazole derivatives, 1-substituted 2-benzylindazolin-3-ones (6– 29, series A) and 3-alkoxy-2-benzyl-2H-indazoles (30–37, series B), containing differently …
Twelve molecules from a series of 35 new 5-nitroindazole derivatives, selected from a successful primary screening on Trypanosoma cruzi epimastigotes, have been evaluated …
In this study, a new series of eleven 5-nitroindazole derivatives (10− 20) and a related 6- nitroquinazoline (21) was synthesized and tested in vitro against different forms of the …
MV Papadopoulou, WD Bloomer… - European journal of …, 2014 - Elsevier
We have previously shown that 3-nitro-1H-1, 2, 4-triazole-based arylamides and arylsulfonamides demonstrate significant activity in vitro against Trypanosoma cruzi, the …
New 5-nitroindazole derivatives were developed and their antichagasic properties studied. Eight compounds (14–18, 20, 26 and 28) displayed remarkable in vitro activities against …
L Friggeri, L Scipione, R Costi, M Kaiser… - ACS medicinal …, 2013 - ACS Publications
The antiparasitic activity of azole and new 4-aminopyridine derivatives has been investigated. The imidazoles 1 and 3–5 showed a potent in vitro antichagasic activity with …
Three different series of new 5‐nitroindazole derivatives—1‐(ω‐aminoalkyl)‐2‐ benzylindazolin‐3‐ones (series A; ten compounds), 3‐(ω‐aminoalkoxy)‐2‐benzylindazoles …
Nitrotriazole-based compounds belonging to various chemical subclasses were found to be very effective against Chagas disease both in vitro and in vivo after a short administration …